Companies
AM
STOXX 600Health Care· Denmark

AMBU-B

Challenger

Ambu

$70.80

+4.50%

Open $67.85·Prev $67.75

as of 17 Apr

CHALLENGER

Power Core

Ambu's moat is the clinical and economic logic of single-use endoscopy, which eliminates reprocessing costs and cross-contamination risk.

Published18 Apr 2026
UniverseSTOXX 600
SectorHealth Care

Direction of Movement

upward

ROC 200

-33.1%

AMBU-B

Ambu

$70.80

+4.50%

Open $67.85·Prev $67.75

as of 17 Apr

Overvalued by 818%

DCF Fair Value: $7.71

View Analysis

News

No recent news available.

Market data unavailable

Company Profile

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.